Expression of genes coding for pS2, c-erbB2, estrogen receptor and the H23 breast tumor-associated antigen. A comparative analysis in breast cancer

Joseph Z. Zaretsky*, Mordechai Weiss, Ilan Tsarfaty, Mara Hareuveni, Daniel H. Wreschner, Iafa Keydar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Abstract

Expression of the gene coding for a new breast tumor-associated antigen, H23, was compared to expression of genes coding for pS2, c-erbB2 and estrogen receptor (ER). Comparison involved mRNA expression in normal and malignant breast tissues as well as in non-breast tumors. Results obtained by RNA dot blot and Northern hybridizations showed that expression of the H23 antigen coding gene is a discriminatory marker in human breast cancer. It is expressed in 92% of breast tumors whereas 69%, 62% and 56% of breast tumors demonstrate significant mRNA levels of c-erbB2, ER and pS2, respectively. Non-malignant or normal breast tissue expresses much lower levels of the H23 antigen mRNA. From the comparative analysis presented here it is concluded that the gene coding for H23 antigen furnishes a most useful marker for human breast cancer.

Original languageEnglish
Pages (from-to)46-50
Number of pages5
JournalFEBS Letters
Volume265
Issue number1-2
DOIs
StatePublished - 4 Jun 1990

Funding

FundersFunder number
Barbara and StevenF riedman
Israel CancerA ssociation
EMBO

    Keywords

    • Breast cancer
    • Breast tumor antigen H23
    • Breast tumor antigen pS2
    • Estrogen receptor
    • Gene expression
    • Oncogene erbB2

    Fingerprint

    Dive into the research topics of 'Expression of genes coding for pS2, c-erbB2, estrogen receptor and the H23 breast tumor-associated antigen. A comparative analysis in breast cancer'. Together they form a unique fingerprint.

    Cite this